Besides the most commonly occurring haematologic adverse events (40% with leukopenia, 34% with anaemia, and 31% with thrombocytopenia), an elevation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) was observed in 19% and 8%, respectively. The gene discussed is GPT; the disease is anemia (phenotype).